Genetic Variants Associated With Cancer Therapy–Induced CardiomyopathyPablo García‐Pavía, Bonnie Ky, Anjali Owens et al.|Circulation|2019Cited by 346
The continuous heart failure spectrum: moving beyond an ejection fraction classificationFilippos Triposkiadis, Gilles W. De Keulenaer, Javed Butler et al.|European Heart Journal|2019Cited by 258
Hypertrophic cardiomyopathy mutations in <i>MYBPC3</i> dysregulate myosinChristopher N. Toepfer, Christine E. Seidman, Hiroko Wakimoto et al.|Science Translational Medicine|2019Cited by 215
Shedding of syndecan-4 promotes immune cell recruitment and mitigates cardiac dysfunction after lipopolysaccharide challenge in miceMari E. Strand, Ida G. Lunde|Journal of Molecular and Cellular Cardiology|2015Cited by 65
The Heparan Sulfate Proteoglycan Glypican-6 Is Upregulated in the Failing Heart, and Regulates Cardiomyocyte Growth through ERK1/2 SignalingArne Olav Melleby, Ida G. Lunde|PLoS ONE|2016Cited by 33